Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Eric K H Chan"'
Autor:
Jane Abbott, Natalie V. J. Aldhouse, Helen Kitchen, Hannah C. Pegram, Fiona Brown, Malcolm Macartney, Angelina Villasis-Keever, Urbano Sbarigia, Tetsuro Ito, Eric K. H. Chan, Patrick T. Kennedy
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-14 (2024)
Abstract Background There is increased emphasis on incorporating patient perspectives and patient-relevant endpoints in drug development. We developed a conceptual model of the impact of chronic hepatitis B (CHB) on patients’ lives and evaluated th
Externí odkaz:
https://doaj.org/article/7ad5c63517c34b14b4f4785d77c71fc3
Autor:
Atul Deodhar, Natalie J. Shiff, Cinty Gong, Eric K. H. Chan, Elizabeth C. Hsia, Kim Hung Lo, Alianu Akawung, Lilianne Kim, Stephen Xu, John D. Reveille
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 4, Pp 983-999 (2023)
Abstract Introduction We studied the effect of intravenous (IV)-golimumab on fatigue and the association of fatigue improvement with clinical response post hoc in adults with active ankylosing spondylitis (AS) in the GO-ALIVE trial. Methods Patients
Externí odkaz:
https://doaj.org/article/bf6b9377ad494054b35304fe6662ddaf
Autor:
Richard H. Osborne, Lauren M. Nelson, Sheri Fehnel, Nicole Williams, Randall H. Bender, Ryan Ziemiecki, Efi Gymnopoulou, Els De Paepe, Yannick Vandendijck, Lindsey Norcross, Esther Heijnen, Gabriela Ispas, Christy Comeaux, Benoit Callendret, Eric K. H. Chan, Jane A. Scott
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-10 (2023)
Abstract Background The Respiratory Infection Intensity and Impact Questionnaire (RiiQ™) is a patient-reported outcome measure designed to assess symptoms and impacts of respiratory syncytial virus (RSV) infection. This study evaluated the construc
Externí odkaz:
https://doaj.org/article/5b724d2c15ed41cd898aa8d9498f4137
Autor:
Carla Romano, Margaret Mayorga, Javier Ruiz-Guiñazú, Géralyn C. Trudel, Sheri Fehnel, Kelly McQuarrie, Eric K. H. Chan, Eva G. Katz
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-9 (2023)
Abstract Background The Symptoms of Infection with Coronavirus-19 (SIC) is a 30-item patient-reported outcome measure to evaluate the presence and severity of COVID-19 signs/symptoms in adults. This study expanded the context of use of the adult SIC
Externí odkaz:
https://doaj.org/article/c3500c799b014fddafeebc405c797628
Autor:
Carla Romano, Sheri Fehnel, Jeffrey Stoddard, Jerald Sadoff, Sandy Lewis, Pauline McNulty, Eric K. H. Chan, Emily Evans, Carol Jamieson, Ashley F. Slagle, Allen Mangel, Kelly McQuarrie
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 6, Iss 1, Pp 1-12 (2022)
Abstract Background Given the urgent need for vaccines and treatments for coronavirus disease 2019 (COVID-19), the Symptoms of Infection with Coronavirus-19 (SIC), a comprehensive, patient-reported outcome (PRO) measure of signs and symptoms associat
Externí odkaz:
https://doaj.org/article/cab0cbcd99a148568acf949b57f3f9da
Autor:
Carla S. Coffin, Sarah Haylock-Jacobs, Karen Doucette, Alnoor Ramji, Hin Hin Ko, David K. Wong, Magdy Elkhashab, Robert Bailey, Julia Uhanova, Gerald Minuk, Keith Tsoi, Alexander Wong, Mang M. Ma, Edward Tam, Mayur Brahmania, Carmine Nudo, Julie Zhu, Christopher F. Lowe, Carla Osiowy, B. Cord Lethebe, Stephen E. Congly, Eric K. H. Chan, Angelina Villasis-Keever, Urbano Sbarigia, Curtis L. Cooper, Scott Fung
Publikováno v:
Viruses, Vol 14, Iss 12, p 2668 (2022)
Background: Hepatitis B surface antigen (HBsAg) loss is associated with improved clinical outcomes for individuals with chronic hepatitis B (CHB); however, the effects of varying HBsAg levels on clinical outcomes in diverse cohorts are understudied.
Externí odkaz:
https://doaj.org/article/6989dedfa34b460aaecea1e961657d56
Autor:
Carla Romano, Margaret Mayorga, Javier Ruiz-Guiñazu, Géralyn C Trudel, Sheri Fehnel, Kelly McQuarrie, Eric K H Chan, Eva G Katz
Publikováno v:
Open Forum Infectious Diseases. 9
Background The Symptoms of Infection with Coronavirus-19 (SIC) is a 30-item patient-reported outcome (PRO) measure developed to assess the presence and severity of COVID-19 signs and symptoms in adults. To further facilitate the evaluation of new vac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a5a2df311732c0a690e22c4dd0d48fe
https://doi.org/10.1093/ofid/ofac492.902
https://doi.org/10.1093/ofid/ofac492.902
Autor:
Christy A Comeaux, Ann R Falsey, Kristi Williams, Stephan Bart, John E Ervin, Arangassery R Bastian, Joris Menten, Els De Paepe, Sjouke Vandenberghe, Eric K H Chan, Jerald Sadoff, Macaya Douoguih, Benoit Callendret, Esther Heijnen
Publikováno v:
Open Forum Infectious Diseases. 9
Background Respiratory syncytial virus (RSV) can cause serious lower respiratory tract disease (LRTD) among older adults. There is no licensed RSV vaccine. In CYPRESS (a randomized, double-blind, placebo-controlled, phase 2b proof-of concept trial; N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4d88135bde6bb50c077017125381d8b
https://doi.org/10.1093/ofid/ofac492.152
https://doi.org/10.1093/ofid/ofac492.152
Autor:
Eric K H Chan, Jeffrey Stoddard, Jerald Sadoff, Yan Liu, Ilse van Dromme, Eva G Katz, Yi-hsuan Liu, Kelly McQuarrie
Publikováno v:
Open Forum Infectious Diseases. 9
Background The Symptoms of Infection with Coronavirus-19 (SIC), a patient reported outcome (PRO) measure, was developed to assess COVID-19 signs and symptoms. Qualitative and cross-sectional studies demonstrated its content validity and preliminary p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42124bfacfae9c02aa066e7e4a5c889a
https://doi.org/10.1093/ofid/ofac492.910
https://doi.org/10.1093/ofid/ofac492.910
Autor:
Eric K. H. Chan, Elizabeth C. Hsia, John D. Reveille, Stephen Xu, L. Kim, Akgun Ince, Atul Deodhar, Kim Hung Lo, N Li, S. Peterson, Diane D. Harrison, Chenglong Han
Publikováno v:
Value in Health. 23:1281-1285
Evaluate the effect of intravenous golimumab on health-related quality of life (HRQoL) in patients with ankylosing spondylitis (AS) through week 28 of the phase III, multicenter, randomized, double-blind, placebo-controlled GO-ALIVE study.Adult patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f21f21e9460f23793e4af4d699416cd
https://doi.org/10.1016/j.jval.2020.04.1837
https://doi.org/10.1016/j.jval.2020.04.1837